May 2019 in “The Journal of Sexual Medicine” Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.
The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.
9 citations
,
July 2024 in “Internal Medicine Journal” Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.
2 citations
,
February 2022 in “Menopause” Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.
November 2024 in “Actas Dermo-Sifiliográficas” May 2023 in “The Journal of Sexual Medicine” Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.
August 2022 in “Journal of drugs in dermatology” Hormone therapy might help improve women's appearance as they age.
1 citations
,
December 2018 in “JURNAL PENDIDIKAN DAN KELUARGA” Using senseviera as a hair tonic can significantly reduce hair loss.
1 citations
,
February 2018 in “InTech eBooks” PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.
August 2020 in “The Journal of Qazvin University of Medical Sciences” Demographic factors like age, education, and marriage duration affect mindfulness in women with PCOS.
1 citations
,
June 2024 in “Revista Colombiana de Endocrinología Diabetes & Metabolismo” The risks of testosterone implants in women outweigh the benefits.
1 citations
,
March 2013 in “The European Journal of Contraception & Reproductive Health Care” The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.
June 2013 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” December 2025 in “Journal of Surgery Research and Practice” Accurate positioning in female hairline transplants creates a natural, feminine look.
June 2026 in “International Journal of Innovative Technologies in Social Science” AI can help diagnose women's metabolic disorders earlier but must be used carefully to avoid bias.
November 2021 in “CRC Press eBooks” Female androgenic alopecia causes hair thinning in women, especially after menopause, and affects their mental well-being.
51 citations
,
April 1999 in “The Journal of Steroid Biochemistry and Molecular Biology” Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.
January 2025 in “Majmaah Journal of Health Sciences” Nearly 70% of postmenopausal women in Saudi Arabia experience hair loss, often linked to early menopause, chronic diseases, family history, and stress.
26 citations
,
July 2012 in “Journal of family planning and reproductive health care” The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.
6 citations
,
September 2005 in “Expert Opinion on Pharmacotherapy” Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.
2 citations
,
April 2023 in “Pharmaceuticals” Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.
40 citations
,
May 2018 in “PubMed” Nutrafol® Women's Capsules safely and effectively promote hair growth in women with thinning hair.
August 2025 in “Editora Pasteur eBooks” Combining conventional and integrative treatments can help reduce hair loss and improve hair growth in women with androgenic alopecia.
1 citations
,
October 2021 in “LGBT health” The review discusses how facial masculinization surgeries are done and their costs.
October 2025 in “Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)” Hormone therapies improve mental health and quality of life for those with gender dysphoria.
April 2006 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” Oral finasteride, combined with drospirenone, improved hair loss in 62% of premenopausal women, with no reported side effects.
2 citations
,
September 2007 in “International Journal of Impotence Research” Local testosterone treatment improved sexual desire in a female with fragile X syndrome.
29 citations
,
May 2010 in “Annals of Pharmacotherapy” Finasteride may help some women with hair loss, but better options exist.
January 2025 in “HORMONES” Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.
April 2020 in “Journal of The American Academy of Dermatology” SMAs improve patient satisfaction and may be cost-effective for female hair loss.